下一代测序在葡萄膜黑色素细胞病变细针穿刺活检中的诊断价值
该研究回顾性分析36例葡萄膜黑色素细胞病变的细针穿刺活检(FNAB)样本,评估细胞学诊断与下一代测序(NGS)的样本充分性。结果显示92%样本足够细胞学诊断,83%足够NGS检测,78%两者均足够;在细胞学不确定的7例中,5例NGS结果明确诊断。结论认为FNAB样本适用于细胞学和NGS检测,NGS有助于不确定病例的诊断和预后评估。
要点
- FNAB样本用于细胞学诊断的充足率为92%(33/36)。
- FNAB样本用于NGS检测的充足率为83%(30/36)。
- 细胞学不确定病例中,NGS可提供诊断性信息(5/7)。
核心结论
- 葡萄膜黑色素细胞病变的FNAB样本足以进行细胞学诊断和NGS检测。
- 在病理学结果不确定的病例中,NGS结果有助于明确诊断。
- 识别的特定分子改变有助于评估预后和指导进一步管理。
研究设计与样本
- 回顾性评估2015年至2018年36例葡萄膜黑色素细胞病变。
- 样本由眼科医生操作的FNAB获取,并分配用于细胞学和NGS。
- 细胞学方法包括直接涂片、液基细胞学玻片、细胞块和黑色素细胞标志物免疫组化染色。
- 所有样本使用基于杂交捕获的NGS检测分子改变。
主要发现
- 36例中33例(92%)有足够材料用于细胞学诊断。
- 36例中30例(83%)有足够材料用于NGS检测。
- 36例中28例(78%)同时足够细胞学诊断和NGS检测。
- 7例细胞学分类为不确定或诊断为「非典型」或「无法诊断」的病例中,5例NGS检测样本足够且对黑色素瘤有诊断性。
- 病理学诊断为黑色素瘤的病例中,20例(87%)NGS检测结果一致,2例缺乏分子改变,1例样本不足无法检测。
临床怎么用
- FNAB样本可同时用于葡萄膜黑色素细胞病变的细胞学诊断和NGS检测。
- 对于细胞学结果不确定的病例,可考虑进行NGS检测以辅助诊断。
- NGS检测发现的特定分子改变可用于评估预后和指导进一步管理。
局限性
- 回顾性研究设计。
- 样本量较小(36例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Uveal melanoma is highly aggressive, and overall prognosis depends on mutation status. Fine-needle aspiration biopsies (FNABs) play an important role in obtaining fresh tissue for cytologic diagnosis and molecular studies. It has been suggested that, although FNAB usually provides high diagnostic accuracy, there may be limited cellularity, which may compromise diagnostic potential for molecular studies. FNABs of uveal melanocytic lesions were evaluated to assess sample adequacy for both cytologic evaluation and next-generation sequencing (NGS). METHODS: The authors retrospectively evaluated 36 cases of melanocytic uveal lesions from 2015 to 2018. Samples were obtained by ophthalmologist-performed FNAB and aliquoted for cytology and NGS. Various combinations of direct smears, liquid-based cytology slides, cell blocks, and immunohistochemical stains for melanocytic markers were performed. All samples were tested for molecular alterations using hybrid-capture-based NGS. RESULTS: There was sufficient material for cytologic diagnosis in 33 of 36 cases (92%), for NGS testing in 30 of 36 cases (83%), and for both cytologic diagnosis and NGS testing in 28 of 36 cases (78%). Of 7 cases that were cytologically categorized as indeterminate or diagnosed as "atypical" or "nondiagnostic," NGS testing was sufficient and diagnostic for melanoma in 5 cases. Of the cases diagnosed as melanoma on pathology, 20 cases (87%) had concordant NGS testing results, 2 lacked molecular alterations, and 1 was insufficient for testing. CONCLUSIONS: FNA sampling of melanocytic uveal lesions is adequate for both cytologic diagnosis and NGS testing. In a subset of cases in which pathologic findings were indeterminate, NGS testing results were clarifying for diagnosis. In addition, specific molecular alterations identified can aid in evaluating prognosis and guide further management.
引用
- Han LM, Khanafshar E, Afshar AR, et al. The diagnostic utility of next-generation sequencing on FNA biopsies of melanocytic uveal lesions. Cancer Cytopathol. 2020. PMID: 32196967. doi:10.1002/cncy.22264
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。